The Valley Desk

Clinical trial reportInvestigational new drugsPublished

Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohort

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Fox Chase Cancer Center, Lewis Katz School of Medicine, Thomas Jefferson University, with Temple Health, Temple University linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
Investigational new drugs
Published
Subject terms
Humans; Carcinoma, Hepatocellular; Liver Neoplasms; Sulfonamides; Aniline Compounds; Antineoplastic Combined Chemotherapy Protocols; Sorafenib; Hepatocellular carcinoma; Bcl2; Navitoclax; Abt-263
PubMed ID
38270822
Added to directory
Source checked

Report a correction or request removal